Boston Partners - VIVOS THERAPEUTICS INC ownership

VIVOS THERAPEUTICS INC's ticker is VVOS and the CUSIP is 92859E108. A total of 28 filers reported holding VIVOS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.

Quarter-by-quarter ownership
Boston Partners ownership history of VIVOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$51,000
-68.1%
78,454
-36.8%
0.00%
Q2 2022$160,000
-56.5%
124,142
-9.6%
0.00%
Q1 2022$368,000
+51.4%
137,354
+27.2%
0.00%
Q4 2021$243,000
+29.3%
108,015
+131.5%
0.00%
Q3 2021$188,00046,6510.00%
Other shareholders
VIVOS THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 162,500$804,0000.46%
BARD ASSOCIATES INC 215,500$1,067,0000.35%
Millrace Asset Group, Inc. 93,993$465,0000.24%
Archon Capital Management LLC 215,000$1,064,0000.12%
Penn Capital Management Company, LLC 223,403$1,106,0000.11%
GRIFFIN ASSET MANAGEMENT, INC. 49,500$245,0000.03%
K2 PRINCIPAL FUND, L.P. 64,746$320,0000.03%
Walleye Capital LLC 150,000$743,0000.02%
WMS Partners, LLC 16,667$153,0000.02%
Avalon Investment & Advisory 189,739$939,0000.02%
View complete list of VIVOS THERAPEUTICS INC shareholders